Catalent | CTLT - Pendapatan Penjualan



Penjualan Perubahan Tanggal
Agilent USD 1.88B 43M 2026-06
AstraZeneca USD 16.21B 830M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Bruker USD 874M 35.5M 2026-09
Centene USD 50.65B 2.93B 2026-09
Charles River Laboratories USD 982.7M 17.3M 2026-09
Cigna USD 73.7B 2B 2026-09
Danaher USD 6.55B 254M 2026-09
Dentsply International USD 836M 62M 2026-09
Elevance Health USD 51.43B 1.63B 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Humana USD 41.16B 270M 2026-09
Illumina USD 1.17B 10M 2026-09
Intuitive Surgical USD 3.05B 158.7M 2026-09
IQVIA Holdings USD 4.43B 60M 2026-09
J&J USD 25.4B 89M 2026-09
Laboratory Of America USD 3.81B 80M 2026-09
Lonza CHF 3.58B 63M 2025-06
McKesson USD 110.96B 5.58B 2026-09
Merck EUR 5.43B 300M 2026-06
Merck USD 18.1B 1.5B 2026-09
Mettler Toledo International USD 1.09B 60M 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Quest Diagnostics USD 3.1B 57M 2026-09
Repligen USD 209M 5M 2026-09
Revvity USD 729M 680K 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Supernus Pharmaceuticals USD 226.8M 7.7M 2026-09
Thermo Fisher Scientific USD 12.14B 147M 2026-09
UnitedHealth USD 112.69B 694M 2026-09
Veradigm USD 142.52M 9.38M 2022-12
Waters USD 1.77B 130M 2026-09
West Pharmaceutical Services USD 874.5M 2.2M 2026-09